IFS
VRTX icon

Ifrah Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Ifrah Financial Services’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.52M Sell
3,056
-221
-7% -$97.9K 0.37% 55
2026
Q1 		$1.46M Sell
3,277
-120
-4% -$56K 0.39% 51
2025
Q4 		$1.54M Sell
3,397
-79
-2% -$34.1K 0.4% 50
2025
Q3 		$1.36M Sell
3,476
-25
-0.7% -$10.4K 0.35% 54
2025
Q2 		$1.56M Sell
3,501
-44
-1% -$20.3K 0.43% 48
2025
Q1 		$1.72M Sell
3,545
-273
-7% -$127K 0.49% 45
2024
Q4 		$1.54M Sell
3,818
-132
-3% -$61.2K 0.42% 48
2024
Q3 		$1.84M Sell
3,950
-102
-3% -$49K 0.5% 46
2024
Q2 		$1.9M Sell
4,052
-403
-9% -$175K 0.54% 44
2024
Q1 		$1.86M Sell
4,455
-102
-2% -$43.1K 0.52% 44
2023
Q4 		$1.85M Sell
4,557
-179
-4% -$66.1K 0.54% 41
2023
Q3 		$1.65M Sell
4,736
-49
-1% -$17.1K 0.51% 46
2023
Q2 		$1.68M Sell
4,785
-76
-2% -$25.6K 0.51% 45
2023
Q1 		$1.53M Sell
4,861
-119
-2% -$35.7K 0.49% 48
2022
Q4 		$1.44M Sell
4,980
-165
-3% -$50.3K 0.47% 48
2022
Q3 		$1.49M Sell
5,145
-38
-0.7% -$10.9K 0.51% 49
2022
Q2 		$1.46M Sell
5,183
-82
-2% -$21.9K 0.47% 50
2022
Q1 		$1.37M Buy
5,265
+2,651
+101% +$629K 0.39% 52
2021
Q4 		$574K Buy
+2,614
New +$508K 0.15% 113

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Ifrah Financial Services's VRTX Position: Q2 2026 in Review

Ifrah Financial Services reduced its Vertex Pharmaceuticals (VRTX) stake by 6.7% in Q2 2026, selling an estimated $97.9K and leaving 3,056 shares worth $1.52M. The position accounts for 0.37% of the portfolio, ranked #55.

Ifrah Financial Services first reported a position in VRTX in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.9M in Q2 2024. 1,754 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Ifrah Financial Services held 3,056 shares of Vertex Pharmaceuticals worth $1.52M as of Q2 2026.
  • Ifrah Financial Services sold 221 Vertex Pharmaceuticals shares in Q2 2026, an estimated $97.9K.
  • Vertex Pharmaceuticals made up 0.37% of Ifrah Financial Services's portfolio in Q2 2026, its #55 holding.
  • Ifrah Financial Services first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Ifrah Financial Services's Vertex Pharmaceuticals position peaked at $1.9M in Q2 2024.
  • 1,754 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Ifrah Financial Services's 13F filing for Q2 2026, filed 21 Jul 2026.